DYNAMICS OF RHINOVIRUS SARS-COV-2 COINFECTIONS AND SUPERINFECTIONS IN HUMAN AIRWAY CULTURES REVEAL TYPE-DEPENDENT VIRAL INTERFERENCE
Abstract
Coinfections between respiratory viruses are frequent but their outcomes are poorly understood. Rhinoviruses (RVs) and SARS-CoV-2 are two clinically relevant respiratory pathogens circulating year-round. We used differentiated human bronchial air-liquid interface (ALI) tissue cultures to study coinfections and staggered superinfections between SARS-CoV-2 BA.2 and two RVs (RV-A1, RV-A16). RV-A16 exerted strong and sustained interference on SARS-CoV-2 replication, whereas RV-A1 showed transient effects. SARS-CoV-2 had limited impact on RVs but persisted long-term despite interference. Superinfection demonstrated that pre-established infection with either virus reduced subsequent replication of the other. RNA-FISH revealed spatially distinct infection foci with few dual-infected cells. Although coinfections prolonged interferon and cytokine secretion, functional assays showed that SARS-CoV-2 BA.2 replication was resistant to IFN, in contrast to Wuhan strains. Pleconaril inhibition of RV-A16 spread reduced its interference, highlighting the role of viral spreading. These findings highlight the complexity of respiratory viral interactions and their potential influence on transmission dynamics during viral co-circulation.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Viral interference between severe acute respiratory syndrome coronavirus 2 and influenza A viruses
Shella Gilbert-Girard, Jocelyne Piret, … Guy Boivin·PLoS PathogensPeer-reviewed·Jul 22, 2024
- Dynamics of interactions between three major respiratory pathogens in reconstituted human epithelium
Aurélien Gibeaud, Charles Terra, … Olivier Terrier·bioRxiv·Nov 17, 2025
- SARS-CoV-2 Mediated Inhibition Of Respiratory Syncytial Virus
Elena M Thornhill, David E. Verhoeven·bioRxiv·Sep 2, 2024
- The impact of RSV/SARS-CoV-2 co-infection on clinical disease and viral replication: insights from a BALB/c mouse model
D. R. Morris, Y. Qu, … R. P. Garofalo·bioRxiv·May 24, 2023
- Airway epithelial interferon response to SARS-CoV-2 is inferior to rhinovirus and heterologous rhinovirus infection suppresses SARS-CoV-2 replication
E. R. Vanderwall, K. A. Barrow, … J. S. Debley·bioRxiv·Nov 20, 2021
- Counterintuitive effect of antiviral therapy on influenza A-SARS-CoV-2 coinfection due to viral interference
N. R. Cheemarla, V. T. Mihaylova, … E. F. Foxman·bioRxiv·Feb 7, 2023